Telix Pharmaceuticals : App 3Z Final Director Interests - A Whitaker

Appendix 3Z Final Director's Interest Notice

Rule 3.19A.3

Appendix 3Z Final Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and

documents given to ASX become ASX's property and may be made public.

Introduced 30/9/2001.

Name of entity Telix Pharmaceuticals Limited

ABN 85 616 620 369

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Anne Whitaker
Date of last notice	4 April 2025
Date that director ceased to be director	29 April 2025

Part 1 - Director's relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Number & class of securities

Nil

+ See chapter 19 for defined terms.

11/3/2002

Appendix 3Z Page 1

Appendix 3Z Final Director's Interest Notice Part 2 - Director's relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest Not applicable

Number & class of securities Nil

Part 3 - Director's interests in contracts

Detail of contract	Not applicable.
Nature of interest	Not applicable.
Name of registered holder (if issued securities)	Not applicable.
No. and class of securities to which interest relates	Not applicable.

+ See chapter 19 for defined terms.

Appendix 3Z Page 2 11/3/2002